UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.980-988

2018

Volltextzugriff (PDF)

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1162-1169

2018

Volltextzugriff (PDF)

Cancer and hepatic steatosis

ESMO open, 2021-08, Vol.6 (4), p.100185-100185, Article 100185

2021

Volltextzugriff (PDF)

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (4), p.451-459

2018

Volltextzugriff (PDF)

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.86-94

2018

Volltextzugriff (PDF)

Exclusion of Varices Via Transient Elastography Combined with Platelet Count According to the Baveno VI Guidelines can Only be Made for Large not Small Varices

Journal of hepatology, 2016, Vol.64 (2), p.S283-S283

2016

Volltextzugriff (PDF)

Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severity

Journal of hepatology, 2017, Vol.66 (1), p.S373-S374

2017

Volltextzugriff (PDF)

Non-alcoholic steatohepatitis is reflected by levels of systemic soluble TREM2 and limited by the recruitment of TREM2-positive macrophages to areas of lipid-induced tissue damage

Atherosclerosis, 2022-08, Vol.355, p.18

2022

Volltextzugriff (PDF)

Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease

Journal of hepatology, 2018-04, Vol.68, p.S707-S708

2018

Volltextzugriff (PDF)

SAT-224 - Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease

Journal of hepatology, 2018-04, Vol.68, p.S707-S708

2018

Volltextzugriff (PDF)

Effect of vardenafil on portal hemodynamics in patients with mild and moderate liver dysfunction: a randomized, placebo-controlled trial

Journal of hepatology, 2018-04, Vol.68, p.S717

2018

Volltextzugriff (PDF)

SAT-243 - Effect of vardenafil on portal hemodynamics in patients with mild and moderate liver dysfunction: a randomized, placebo-controlled trial

Journal of hepatology, 2018-04, Vol.68, p.S717-S717

2018

Volltextzugriff (PDF)

Resolution of clinically significant portal hypertension after sustained virologic response to interferon-free regimens prevents hepatic decompensation

Journal of hepatology, 2018-04, Vol.68, p.S532

2018

Volltextzugriff (PDF)

FRI-376 - Resolution of clinically significant portal hypertension after sustained virologic response to interferon-free regimens prevents hepatic decompensation

Journal of hepatology, 2018-04, Vol.68, p.S532-S532

2018

Volltextzugriff (PDF)

THU-375 - Exclusion of Varices Via Transient Elastography Combined with Platelet Count According to the Baveno VI Guidelines can Only be Made for Large not Small Varices

Journal of hepatology, 2016, Vol.64 (2), p.S283-S283

2016

Volltextzugriff (PDF)

FRI-015 - Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severity

Journal of hepatology, 2017, Vol.66 (1), p.S373-S374

2017

Volltextzugriff (PDF)

VON WILLEBRAND FACTOR ANTIGEN (vWF-Ag): A NON-INVASIVE PREDICTOR OF TREATMENT RESPONSE AND SERIOUS ADVERSE EVENTS IN HCV PATIENTS WITH INTERFERON TRIPLE THERAPY

Digestive and liver disease, 2016-10, Vol.48 (10), p.1194-1199

2016

Volltextzugriff (PDF)

Calling Student Referees to Promote Small-Group Discourse

The Mathematics teacher, 2024-03, Vol.117 (3), p.195-201

2024

Volltextzugriff (PDF)

Von Willebrand factor antigen is linked to bacterial translocation, inflammation, as well as procoagulant imbalance and predicts complications of cirrhosis independently of portal hypertension severity

Zeitschrift für Gastroenterologie, 2017, Vol.55 (5), p.e28-e56

2017

Volltextzugriff (PDF)

NASH SEVERITY ASSESSED BY THE NAFLD ACTIVITY SCORE (NAS) DOES NOT ADD PROGNOSTIC INFORMATION TO FIBROSIS STAGE IN PATIENTS WITH NAFLD

HEPATOLOGY, 2023, Vol.78, p.S1018

2023

Volltextzugriff (PDF)

LIVER STIFFNESS MEASUREMENT BASED COMPOSITE SCORES HAVE COMPARABLE PROGNOSTIC PERFORMANCE TO HISTOLOGICALLY ASSESSED FIBROSIS STAGE

HEPATOLOGY, 2023, Vol.78, p.S995

2023

Volltextzugriff (PDF)

Irreversibility and the Arrow of Time in a Quenched Quantum System

Physical review letters, 2015-11, Vol.115 (19), p.190601-190601, Article 190601

2015

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Cancer and hepatic steatosis

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Exclusion of Varices Via Transient Elastography Combined with Platelet Count According to the Baveno VI Guidelines can Only be Made for Large not Small Varices

Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severity

Non-alcoholic steatohepatitis is reflected by levels of systemic soluble TREM2 and limited by the recruitment of TREM2-positive macrophages to areas of lipid-induced tissue damage

Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease

SAT-224 - Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease

Effect of vardenafil on portal hemodynamics in patients with mild and moderate liver dysfunction: a randomized, placebo-controlled trial

SAT-243 - Effect of vardenafil on portal hemodynamics in patients with mild and moderate liver dysfunction: a randomized, placebo-controlled trial

Resolution of clinically significant portal hypertension after sustained virologic response to interferon-free regimens prevents hepatic decompensation

FRI-376 - Resolution of clinically significant portal hypertension after sustained virologic response to interferon-free regimens prevents hepatic decompensation

THU-375 - Exclusion of Varices Via Transient Elastography Combined with Platelet Count According to the Baveno VI Guidelines can Only be Made for Large not Small Varices

FRI-015 - Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severity

VON WILLEBRAND FACTOR ANTIGEN (vWF-Ag): A NON-INVASIVE PREDICTOR OF TREATMENT RESPONSE AND SERIOUS ADVERSE EVENTS IN HCV PATIENTS WITH INTERFERON TRIPLE THERAPY

Calling Student Referees to Promote Small-Group Discourse

Von Willebrand factor antigen is linked to bacterial translocation, inflammation, as well as procoagulant imbalance and predicts complications of cirrhosis independently of portal hypertension severity

NASH SEVERITY ASSESSED BY THE NAFLD ACTIVITY SCORE (NAS) DOES NOT ADD PROGNOSTIC INFORMATION TO FIBROSIS STAGE IN PATIENTS WITH NAFLD

CLASSIFICATION ACCORDING TO SEQUENTIALLY COMBINED NON-INVASIVE TESTS CARRIES PROGNOSTIC VALUE IN PATIENTS WITH NAFLD

HISTOLOGICALLY ASSESSED FIBROSIS IS THE MAIN DETERMINANT OF PROGNOSIS IN PATIENTS IN NAFLD

COMPOSITE SCORES THAT INCLUDE LIVER STIFFNESS MEASUREMENT CAN PREDICT OUTCOMES IN PATIENTS WITH NAFLD

LIVER STIFFNESS MEASUREMENT BASED COMPOSITE SCORES HAVE COMPARABLE PROGNOSTIC PERFORMANCE TO HISTOLOGICALLY ASSESSED FIBROSIS STAGE

Irreversibility and the Arrow of Time in a Quenched Quantum System

Suchergebnisse filtern